Myelosuppression after methotrexate, mitoxantrone, and mitomycin C

Lancet. 1987 May 23;1(8543):1211. doi: 10.1016/s0140-6736(87)92189-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bone Marrow / drug effects*
  • Breast Neoplasms / drug therapy
  • Clinical Trials as Topic
  • Female
  • Humans
  • Methotrexate / adverse effects
  • Mitomycin
  • Mitomycins / adverse effects
  • Mitoxantrone / adverse effects
  • Random Allocation

Substances

  • Mitomycins
  • Mitomycin
  • Mitoxantrone
  • Methotrexate